Risk Factors for Secondary Hyperparathyroidism in a Nursing Home Population
Overview
Affiliations
Objective: Secondary hyperparathyroidism may cause bone loss and structural deterioration of bone and may thus be a cause of fracture in the elderly. Vitamin D deficiency, renal impairment and medications are potential causes of hyperparathyroidism and may also directly predispose to fracture. We present the first findings of an ongoing study of hip fracture, vitamin D deficiency and hyperparathyroidism in a large Australian nursing home.
Design: Descriptive prevalence study.
Patients: Two hundred and fifty-one nursing home residents were eligible for inclusion. Informed consent and successful venepuncture were obtained for 99. Residents were of median age 83 years with interquartile range (IR) 77-89 years.
Measurements: 25-Hydroxyvitamin D (25OHD), intact parathyroid hormone (PTH), creatinine and biochemistry, demographic data and current medications.
Results: Fifty-two per cent of 99 subjects had 25OHD below the reference range of 28-165 nmol/l and 96.5% were below the reference range mean. Those with low 25OHD had lower plasma calcium corrected for albumin than those with normal 25OHD (medians 2.34 vs 2.41 mmol/l, 95% confidence interval for the difference between medians (CI) -0.10 to -0.04 mmol/l, P = 0.0001) and higher PTH (medians 5.8 vs 3.9 pmol/l, CI 0.10-2.6 pmol/l, P = 0.0360). Twenty-eight per cent of 97 residents had PTH above the upper reference range limit of 6.5 pmol/l. Residents receiving frusemide had higher PTH than other residents (medians 6.95 vs 3.45 pmol/l, CI 1.9-4.2 pmol/l, P < 0.0001). In linear modelling, the most important predictor of the natural logarithm of PTH was daily frusemide dose, adjusted R2 (Ra2) = 31.8%, F = 39.3, P < 0.001. Creatinine and the reciprocal of 25OHD were other significant predictors with the final Ra2 = 39.4%, F = 17.7, P < 0.001.
Conclusions: Vitamin D deficiency is a common risk factor for secondary hyperparathyroidism in nursing home residents despite a climate in which vitamin D nutrition is thought to be ample. However, the daily frusemide dose is a more important predictor of PTH in this population.
Vitamin D deficiency in elderly: Risk factors and drugs impact on vitamin D status.
Kweder H, Eidi H Avicenna J Med. 2018; 8(4):139-146.
PMID: 30319955 PMC: 6178567. DOI: 10.4103/ajm.AJM_20_18.
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Elias R, Moyses R Int Urol Nephrol. 2017; 49(10):1815-1821.
PMID: 28695313 DOI: 10.1007/s11255-017-1650-7.
Kubota T, Namba N, Kurotobi S, Kogaki S, Hirai H, Kitaoka T Clin Pediatr Endocrinol. 2014; 15(3):101-7.
PMID: 24790329 PMC: 4004841. DOI: 10.1297/cpe.15.101.
Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.
Rolland Y, de Souto Barreto P, Abellan van Kan G, Annweiler C, Beauchet O, Bischoff-Ferrari H J Nutr Health Aging. 2013; 17(4):402-12.
PMID: 23538667 DOI: 10.1007/s12603-013-0007-x.
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M Clin J Am Soc Nephrol. 2012; 7(5):820-8.
PMID: 22383746 PMC: 3338283. DOI: 10.2215/CJN.11721111.